Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A carcinoma that arises from epithelial cells of the penis
Biomarker and diagnostic research for penile carcinoma has been reported in the published literature.
41 clinical trials registered, 13 recruiting. Interventions under study include drug therapy, procedural interventions, other interventions, and biologic therapy. Pipeline includes 2 PHASE3, 19 PHASE2, 10 PHASE1. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT05969860](https://clinicaltrials.gov/study/NCT05969860) |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 5:31 AM UTC
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer |
PHASE2 |
Mayo Clinic |
RECRUITING |
[NCT06683846](https://clinicaltrials.gov/study/NCT06683846) | Ivonescimab in the Treatment of Multiple Advanced Tumors | PHASE2 | Fudan University | RECRUITING |
[NCT06415318](https://clinicaltrials.gov/study/NCT06415318) | TIP Regimen Combined With Triplizumab Neoadjuvant Therapy for Locally Advanced Penile Cancer | PHASE2 | Sun Yat-sen University | RECRUITING |
[NCT05526989](https://clinicaltrials.gov/study/NCT05526989) | Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma | PHASE2 | H. Lee Moffitt Cancer Center and Research Institute | RECRUITING |
[NCT05264337](https://clinicaltrials.gov/study/NCT05264337) | Lymphedema After Urologic Surgery | — | Vastra Gotaland Region | RECRUITING |
55 publications have been identified in PubMed for penile carcinoma. Research spans Case Report / Case Series (29%), Clinical Trial Publication (16%), and Basic Science / Preclinical (16%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 16 | 29% |
Clinical study results | 9 | 16% |
Laboratory research | 9 | 16% |
Research summaries | 7 | 13% |
Disease patterns and progression | 6 | 11% |
New treatment approaches | 5 | 9% |
Testing and diagnosis research | 3 | 5% |
Broad S (2026). [PMID: 41288089](https://pubmed.ncbi.nlm.nih.gov/41288089/). *Molecular oncology*. [Basic Science / Preclinical]
Stelmach R (2026). [PMID: 40324348](https://pubmed.ncbi.nlm.nih.gov/40324348/). *Oncology research and treatment*. [Clinical Trial Publication]
Klier J (2026). [PMID: 41916386](https://pubmed.ncbi.nlm.nih.gov/41916386/). *Aktuelle Urol*. [Epidemiology / Natural History]
Fiegl A (2026). [PMID: 40719092](https://pubmed.ncbi.nlm.nih.gov/40719092/). *Aktuelle Urologie*. [Review / Meta-Analysis]
Masaki K (2026). [PMID: 41836245](https://pubmed.ncbi.nlm.nih.gov/41836245/). *Frontiers in oncology*. [Case Report / Case Series]
Ermakov MS (2026). [PMID: 42031074](https://pubmed.ncbi.nlm.nih.gov/42031074/). *Lab Invest*. [Basic Science / Preclinical]
Martin GE (2026). [PMID: 41341992](https://pubmed.ncbi.nlm.nih.gov/41341992/). *Urology case reports*. [Case Report / Case Series]
Thiagarajan SK (2026). [PMID: 41947256](https://pubmed.ncbi.nlm.nih.gov/41947256/). *J Med Case Rep*. [Case Report / Case Series]
Donmez K (2026). [PMID: 41800517](https://pubmed.ncbi.nlm.nih.gov/41800517/). *Can J Urol*. [Review / Meta-Analysis]
Marson L (2026). [PMID: 41917338](https://pubmed.ncbi.nlm.nih.gov/41917338/). *NPJ Precis Oncol*. [Gene Therapy / Novel Therapeutics]